No definition available.
Mucinous and mucinous cystic tumor, excluding all cancers (controls excluding all cancers)
C3_OVARY_MUCINO_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
233 |
4. Check minimum number of eventsNone |
233 |
5. Include endpointsNone |
233 |
6. Filter based on genotype QC (FinnGen only) |
233 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Mucinous and mucinous cystic tumor, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)
- malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 233 | 233 | - |
| Unadjusted period prevalence (%) | 0.08 | 0.08 | - |
| Median age at first event (years) | 54.36 | 54.36 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 142
- Matched controls
- 1420
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
+∞
155.0
119
*
8470/3-C56.9
ICD-O-3
Mucinous cystadenocarcinoma, NOS, of ovary
+∞
114.6
94
*
8480/3-C56.9
ICD-O-3
Mucinous adenocarcinoma of ovary
+∞
53.6
48
*
JAL30
NOMESCO Finland
Omentectomy
381.5
52.9
50
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
44.1
40
*
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
54.1
42.7
50
14
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
39.4
36
*
JEA00
NOMESCO Finland
Appendectomy
25.0
35.5
51
31
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
30.2
32.1
43
20
LCD00
NOMESCO Finland
Hysterectomy
20.7
32.0
49
35
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
30.8
31.5
42
19
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
24.7
23
*
H02AB02
ATC
dexamethasone; systemic
57.6
24.4
28
6
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
22.5
21
*
A04AA01
ATC
ondansetron; systemic, rectal
19.9
19.3
29
18
WX302
NOMESCO Finland
Thoracal epidural anesthesy
21.9
18.7
27
15
121
Kela drug reimbursment
Severe hypofunction of sexual glands
22.4
18.1
26
14
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
18.1
17
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
18.1
17
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
14.3
17.6
30
26
JAL00
NOMESCO Finland
Biopsy of peritoneum
102.3
17.0
18
*
D39.11
ICD-10 Finland
Epithelial tumor of uncertain nature in the ovary
54.4
16.5
19
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
15.9
15
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
5.8
15.4
49
118
A03FA01
ATC
metoclopramide; systemic, rectal
5.9
15.3
48
113
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
20.3
14.3
21
12
A04AA02
ATC
granisetron; systemic, transdermal
+∞
13.8
13
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
13.8
13
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
13.8
13
*
B01AB10
ATC
tinzaparin; parenteral
10.2
13.5
27
32
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
4.0
13.5
84
380
JN4BD
NOMESCO Finland
Extensive body CT
11.0
13.1
25
27
B01AB05
ATC
enoxaparin; parenteral
3.9
12.4
68
271
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
12.1
11.7
21
20
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
11.6
11
*
Z31.5
ICD-10 Finland
Genetic counselling
10.2
11.3
22
25
1830A
ICD-9 Finland
Malignant neoplasm of ovary and other uterine adnexa, Ovary
+∞
10.5
10
*
C567
ICD-10 Finland
NA
+∞
10.5
10
*
130
Kela drug reimbursment
Malignant tumour
+∞
10.5
10
*
115
Kela drug reimbursment
Breast cancer
+∞
10.5
10
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.5
10
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.2
10.2
28
54
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
18.4
10.1
15
9
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
59.1
9.8
11
*
L03AA02
ATC
filgrastim; parenteral
+∞
9.5
9
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
+∞
9.5
9
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
9.5
9
*
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
+∞
9.5
9
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
4.1
8.8
37
113
JN4AD
NOMESCO Finland
Body CT examination
11.8
8.5
15
14
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
8.4
8
*
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
35.6
8.2
10
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
14.4
7.5
12
9
A04AA03
ATC
tropisetron; systemic
+∞
7.3
7
*
X77
ICPC
Malignant neopl genital female other
+∞
7.3
7
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
7.3
7
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
7.3
7
*
L02BG04
ATC
letrozole; oral
31.8
7.2
9
*
D27.91
ICD-10 Finland
Benign epithelial tumor of the ovary (ovary)
10.9
7.2
13
13
R18
ICD-10 Finland
Ascites
42.1
6.8
8
*
TPH07
NOMESCO Finland
Cathetrisation of artery
5.2
6.7
20
43
JAH00
NOMESCO Finland
Laparotomy
19.1
6.3
9
5
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
6.3
6
*
18301
ICD-8 Finland
Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary
+∞
6.3
6
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
6.3
6
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
6.3
6
*
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
3.4
6.2
31
109
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4281824)
46
13
43.84
74.79
1.2
1.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
79
96
11.94
64.46
2.8
1.4
ug/l
13.1
2.7
1.35
63
74
(4035726)
47
47
12.27
43.04
1.2
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
15
6
26.55
11.29
1.1
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
94
520
2.35
8.88
2.4
1.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
72
404
2.13
6.21
2.3
1.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
122
836
1.96
5.99
4.4
3.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
40
178
2.51
5.90
8.9
5.5
mmol/l
1.2
1.9
0.56
33
147
(3000991) Gas panel - Venous blood
30
121
2.70
5.38
10.8
5.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
104
700
1.88
5.17
9.8
7.3
inr
1.3
1.2
0.27
26
207
(3023368) Bacteria identified in Blood by Culture
64
380
1.94
4.57
4.6
3.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
103
714
1.79
4.50
2.0
1.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
72
2.94
4.41
13.1
7.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
6
11.97
4.30
3.3
2.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
111
796
1.75
4.25
4.8
3.2
g/l
34.8
36.2
1.42
105
730
(3033658) Prothrombin time (PT) actual/Normal
67
422
1.82
3.94
4.3
2.9
%
95.2
95.7
0.06
67
403
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
113
828
1.71
3.91
6.8
4.5
mmol/l
1.2
1.2
1.91
101
735
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
34
3.67
3.82
2.8
2.9
u/ml
0.3
0.4
—
6
21
(3010813) Leukocytes [#/volume] in Blood
206
2206
0.43
3.71
27.6
17.1
e9/l
6.7
6.5
0.63
197
2148
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
47
269
1.94
3.69
1.6
1.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
174
1966
0.55
3.68
6.1
5.3
mu/l
1.9
2.5
0.45
157
1807
(3007461) Platelets [#/volume] in Blood
206
2205
0.43
3.65
27.6
17.1
e9/l
271.9
261.6
1.10
200
2152
(3026361) Erythrocytes [#/volume] in Blood
206
2205
0.43
3.65
27.6
17.1
e12/l
4.3
4.4
3.15
197
2144
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
181
2016
0.54
3.46
4.1
4.6
mmol/l
5.9
5.9
0.35
156
1849
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
166
1893
0.57
3.46
5.3
5.8
mmol/mol
39.6
39.5
0.04
148
1760
(3002256) Pathology report gross observation
32
163
2.12
3.45
1.2
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
35
186
2.04
3.38
1.5
1.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
14
5.88
3.37
3.1
2.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
35
187
2.03
3.33
1.5
1.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
120
923
1.62
3.25
7.5
4.9
mmol/l
1.2
1.2
3.26
102
794
(3019060) Gas panel - Arterial blood
22
99
2.35
3.17
2.7
5.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
188
2062
0.54
3.12
4.1
5.1
mmol/l
2.8
2.8
0.11
165
1901
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
20
88
2.39
3.03
14.3
5.2
mmol/l
25.4
25.8
0.16
20
88
(3014111) Lactate [Moles/volume] in Serum or Plasma
27
136
2.11
3.00
11.4
4.3
mmol/l
1.2
1.3
0.28
27
131
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
20
91
2.31
2.83
12.3
6.4
%
0.5
0.7
1.05
20
91
(3013650) Neutrophils [#/volume] in Blood by Automated count
129
1032
1.56
2.81
14.6
6.2
e9/l
4.0
4.2
0.46
105
891
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
20
92
2.28
2.76
11.9
6.4
%
1.2
1.4
0.67
20
92
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
20
4.10
2.59
1.1
1.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
40
244
1.77
2.56
2.6
1.6
s
28.9
29.3
0.16
40
237
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
11
5.57
2.56
1.2
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
75
541
1.57
2.53
4.1
2.9
ph
7.4
7.4
—
9
91
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
185
2020
0.59
2.52
3.8
4.6
mmol/l
4.8
4.9
0.15
166
1869
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
16
4.48
2.49
1.1
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
12
45
2.76
2.49
3.2
3.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
13
4.71
2.28
1.2
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
200
2132
0.56
2.24
13.8
8.6
u/l
23.2
23.2
0.00
190
2046
(3013826) Glucose [Moles/volume] in Serum or Plasma
131
1089
1.46
2.15
6.5
3.7
mmol/l
6.6
6.6
0.02
121
991
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
185
2007
0.62
2.15
3.7
4.5
mmol/l
1.6
1.6
0.85
163
1851
(3049717) Cytology report of Urine Cyto stain
12
49
2.53
2.14
4.1
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
22
119
1.94
2.05
1.6
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
21
3.40
1.98
1.6
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
114
934
1.43
1.96
8.4
3.2
umol/l
9.3
10.4
1.66
108
869
(3007853) Bacteria identified in Skin by Aerobe culture
32
198
1.71
1.96
1.5
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
183
0.42
1.91
2.0
1.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
25
404
0.57
1.89
1.6
1.3
g/l
1.9
2.4
1.87
18
232
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
33
492
0.62
1.81
1.2
1.3
u/ml
0.6
2.3
1.73
13
140
(3020564) Creatinine [Moles/volume] in Serum or Plasma
199
2111
0.61
1.81
23.1
12.9
umol/l
68.8
69.7
0.25
199
2111
(1761482) Bacteria [#/volume] in Urine by Culture
12
55
2.25
1.70
5.4
3.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
40
273
1.56
1.69
3.6
2.7
e6/l
2.7
4.0
0.49
22
128
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
178
1927
0.68
1.68
3.4
4.1
mmol/l
1.3
1.2
0.92
152
1756
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
31
2.64
1.67
1.6
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
25
2.85
1.66
1.4
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
82
650
1.40
1.64
4.0
1.9
mmol/l
2.4
2.4
0.67
69
541
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
14
3.62
1.62
1.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
26
2.74
1.59
1.0
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
35
235
1.58
1.59
1.7
1.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
74
916
0.72
1.54
2.6
2.7
ug/l
105.4
84.3
0.66
64
846
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
25
381
0.61
1.50
1.6
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
74
912
0.72
1.49
2.0
2.4
nmol/l
75.9
79.7
0.51
61
813
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
42
299
1.49
1.47
3.2
2.5
e6/l
1.0
1.2
0.28
23
154
(36660697) Celiac disease serology panel - Serum
9
179
0.48
1.47
1.1
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
60
462
1.40
1.40
1.3
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
17
2.98
1.36
2.0
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
14
76
1.90
1.33
4.4
2.9
%
45.3
47.2
0.12
14
76
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
24
2.54
1.31
1.8
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
117
0.41
1.29
2.6
1.9
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
162
1466
1.34
1.27
8.7
5.1
u/l
78.6
75.9
0.48
148
1345
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
36
2.26
1.25
1.6
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
176
1886
0.73
1.24
18.4
10.3
ml/min/173m2
82.1
79.3
0.90
143
1509
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
8
37
2.20
1.22
1.1
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
8
37
2.20
1.22
1.1
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
110
1255
0.77
1.21
2.4
3.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
38
2.14
1.19
3.0
2.4
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
8
39
2.09
1.16
4.9
2.5
mmol/l
8.2
7.5
—
8
39
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
20
2.53
1.15
1.2
1.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
15
88
1.75
1.14
2.7
2.0
%
0.9
1.1
0.36
15
88
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
16
96
1.72
1.13
1.4
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
200
0.58
1.04
1.9
2.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
54
1.89
0.98
1.2
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
30
0.00
0.98
0.0
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
8
144
0.54
0.97
1.3
1.4
—
40.7
—
0
7
(3021879) Hepatitis B virus core Ab [Presence] in Serum
16
102
1.61
0.93
1.1
1.3
—
—
—
0
0
(3012544) pH of Venous blood
23
160
1.49
0.93
4.6
3.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
101
0.48
0.92
1.2
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
65
540
1.28
0.91
4.6
2.9
e6/l
47.9
42.6
0.07
49
407
(40761511) CBC panel - Blood by Automated count
199
2073
0.73
0.90
15.5
11.0
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
8
42
1.94
0.89
4.9
2.4
mmol/l
1.4
1.5
—
8
42
(3018095) Leukocytes [#/volume] in Urine
77
655
1.26
0.89
6.1
3.6
e6/l
234.8
110.0
0.40
54
451
(3030467) Casts [#/volume] in Urine by Automated count
60
496
1.28
0.87
4.5
2.9
e6/l
0.3
0.5
0.63
47
365
(3013707) Erythrocyte sedimentation rate by Westergren method
141
1529
0.80
0.86
4.1
4.3
mm/h
17.0
12.0
2.13
130
1398
(36304419) Bacteria [Presence] in Urine
59
488
1.28
0.85
4.4
2.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
46
1.76
0.83
1.4
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
70
596
1.25
0.79
6.4
5.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
1.8
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
4.8
—
366.8
—
0
20
(3023103) Potassium [Moles/volume] in Serum or Plasma
198
2058
0.75
0.79
21.8
13.4
mmol/l
3.9
3.9
0.66
192
1996
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
38
1.87
0.74
1.1
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
44
357
1.29
0.74
4.3
2.5
mosm/kgh2o
495.8
526.3
0.37
37
310
(3000330) Specific gravity of Urine by Test strip
15
101
1.52
0.72
4.8
3.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
52
617
0.80
0.71
3.0
3.0
mmol/l
6.8
6.5
0.15
46
513
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
41
1.73
0.70
1.1
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
116
0.59
0.70
1.0
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
20
270
0.72
0.69
3.9
4.5
%
32.6
33.3
—
9
165
(40758558) Short blood count panel - Blood
53
444
1.25
0.69
14.7
4.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
161
1705
0.82
0.68
5.2
4.4
pmol/l
15.2
14.7
1.90
147
1562
(3035285) Chloride [Moles/volume] in Venous blood
5
28
1.80
0.66
5.2
2.1
mmol/l
103.0
106.2
—
5
28
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
28
1.80
0.66
5.2
2.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
28
1.80
0.66
5.2
2.1
mmol/l
4.4
4.0
—
5
28
(3019832) Treponema pallidum Ab [Presence] in Serum
11
165
0.65
0.65
2.1
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
7
44
1.61
0.65
1.1
1.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
5
29
1.74
0.64
1.0
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
21
156
1.38
0.63
5.2
3.8
—
—
—
0
0
(3044889) 12 lead EKG panel
129
1388
0.84
0.62
4.0
3.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
77
866
0.83
0.62
2.0
2.0
pmol/l
96.7
99.1
0.16
40
398
(3002523) Influenza virus A Ag [Presence] in Specimen
5
30
1.68
0.62
1.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
30
1.68
0.62
1.0
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3020891) Body temperature
10
64
1.59
0.59
2.8
5.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
8
53
1.53
0.59
1.9
1.6
—
0.3
—
0
7
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
69
605
1.20
0.59
3.3
2.0
u/l
51.4
57.2
0.45
62
557
(3048689) Calprotectin [Mass/mass] in Stool
21
273
0.75
0.59
1.6
2.2
ug/g
118.7
116.7
0.02
15
210
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.1
—
85.4
—
0
5
(3009261) Glucose [Presence] in Urine by Test strip
111
1016
1.18
0.58
4.8
3.8
estimate
0.0
0.0
0.50
22
181
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
73
646
1.19
0.56
4.3
2.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
68
599
1.19
0.55
4.8
2.4
u/l
29.1
28.3
0.11
63
572
(3021788) Differential panel - Synovial fluid
6
39
1.55
0.53
1.3
1.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
191
1976
0.81
0.53
17.3
11.4
mg/l
30.6
18.9
4.31
165
1505
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
6
99
0.60
0.53
5.8
3.5
kpa
5.1
5.3
—
6
92
(3017181) Myelocytes/100 leukocytes in Blood
17
127
1.37
0.51
3.5
3.9
%
1.7
0.3
—
6
23
(1761868) Lipid panel - Serum or Plasma
65
730
0.85
0.50
2.8
3.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
11
76
1.47
0.49
1.3
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
68
1.49
0.47
1.7
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
43
498
0.83
0.47
1.5
1.5
nmol/l
19.3
22.8
0.83
36
425
(3020630) Protein [Mass/volume] in Serum or Plasma
19
147
1.32
0.47
5.5
1.4
g/l
65.5
68.0
1.32
19
134
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
81
0.61
0.46
1.4
1.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
109
1010
1.15
0.46
7.2
5.2
estimate
0.0
0.0
0.00
20
174
(3021440) Promyelocytes/100 leukocytes in Blood
16
121
1.35
0.45
3.7
4.1
%
0.2
0.0
—
5
22
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
6
93
0.64
0.43
5.7
3.3
mmol/l
2.5
2.0
—
6
70
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
50
439
1.18
0.42
2.1
1.7
mg/l
1.4
0.9
1.08
44
343
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
33
1.53
0.41
3.8
2.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(4268621)
0
16
0.00
0.41
0.0
2.1
—
—
—
0
0
(4027681)
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.1
—
1.1
—
0
9
(21494755) Public health laboratory ask at order entry panel
13
171
0.75
0.41
1.2
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
102
0.68
0.40
1.3
1.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
18
0.00
0.40
0.0
3.8
—
11.2
—
0
12
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
71
1.43
0.40
1.9
1.6
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
5
35
1.44
0.39
7.8
3.8
kpa
8.4
8.5
—
5
35
(3013290) Carbon dioxide [Partial pressure] in Blood
5
35
1.44
0.39
7.8
3.8
kpa
4.8
5.2
—
5
35
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
36
416
0.84
0.39
1.3
1.3
iu/ml
46.9
37.7
—
10
140
(3021589) Normoblasts [#/volume] in Blood
90
832
1.13
0.38
12.2
7.6
e9/l
0.0
0.0
0.06
72
674
(40768797) Stomach Pathology biopsy report
26
309
0.82
0.38
1.3
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
78
0.63
0.36
1.4
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
87
0.68
0.33
1.5
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
46
1.31
0.33
1.2
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
20
165
1.23
0.32
1.2
1.2
iu/ml
192.7
133.6
—
8
67
(3012516) Albumin [Mass/volume] in Urine
53
584
0.88
0.32
3.5
3.1
mg/l
47.9
529.3
1.25
31
340
(3020682) Albumin/Creatinine [Ratio] in Urine
56
613
0.89
0.30
3.7
3.8
mg/mmol
9.8
5.1
0.54
34
354
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
19
227
0.82
0.30
1.8
1.7
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
8
108
0.73
0.29
2.4
1.5
g/l
0.9
1.3
—
8
102
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
27
234
1.17
0.28
1.3
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
35
392
0.87
0.27
1.9
1.7
nmol/l
1115.9
1162.3
0.08
18
291
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
160
0.80
0.27
1.1
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
20
169
1.20
0.27
1.2
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
5
73
0.68
0.26
1.2
1.3
—
2.2
—
0
14
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
73
0.68
0.26
9.0
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
52
477
1.12
0.25
3.2
2.0
umol/l
9775.5
5410.8
0.18
47
401
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
126
0.78
0.25
1.9
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
161
1655
0.91
0.23
23.1
13.7
%
13.9
13.6
1.92
155
1620
(3006315) Basophils [#/volume] in Blood
89
938
0.92
0.23
6.8
4.9
e9/l
0.0
0.0
0.47
72
797
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
12
97
1.25
0.23
1.3
1.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
43
392
1.12
0.23
3.6
2.3
e6/l
5.6
7.7
0.85
37
348
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
18
153
1.19
0.23
2.9
1.8
ml/min/173m2
57.7
67.4
—
6
63
(3027456) Digoxin [Moles/volume] in Serum or Plasma
5
39
1.29
0.23
2.0
3.7
nmol/l
0.7
0.9
—
5
30
(3024928) Oxygen saturation in Venous blood
5
40
1.26
0.22
1.6
2.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
74
785
0.92
0.22
5.1
3.9
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
4.6
—
0
11
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
10.3
—
0.7
—
0
10
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
31.6
—
0
10
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
17.9
—
820.0
—
0
10
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
25.4
—
1604.3
—
0
10
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
11
89
1.25
0.21
1.0
1.3
—
1.5
—
0
7
(3026008) Bacteria identified in Urine by Culture
75
708
1.09
0.21
4.4
3.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.9
—
56.4
—
0
8
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
18
155
1.17
0.20
2.9
3.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
9
112
0.80
0.20
1.7
2.4
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.4
—
1.9
—
0
14
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
14
0.00
0.20
0.0
2.6
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
19
217
0.86
0.19
1.3
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
104
998
1.08
0.19
4.8
3.8
estimate
0.0
0.0
0.00
20
183
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
52
1.16
0.19
1.7
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
40
433
0.91
0.18
1.4
1.7
pmol/l
459.3
452.4
0.04
33
354
(3001604) Monocytes [#/volume] in Blood
89
930
0.93
0.18
6.8
4.9
e9/l
0.6
0.6
0.17
73
794
(3037467) Urinalysis macro (dipstick) panel - Urine
143
1392
1.07
0.17
5.4
4.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
69
0.72
0.17
9.0
1.3
g/l
7.0
10.4
—
5
58
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
6
77
0.77
0.16
2.0
2.5
u/l
40.5
42.5
—
6
67
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
79
0.75
0.15
2.8
1.7
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
6
79
0.75
0.15
1.2
1.3
—
23.7
—
0
6
(3045414) Leukocytes [Presence] in Urine
7
86
0.81
0.15
1.6
1.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
92
954
0.94
0.14
6.8
4.9
e9/l
1.7
1.9
1.79
78
835
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
15
170
0.87
0.14
1.6
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
49
463
1.07
0.13
1.4
1.4
—
—
—
0
0
(3000492) Spirometry study
14
158
0.88
0.12
1.5
1.4
—
—
—
0
0
(3019225) pH of Specimen
21
191
1.11
0.12
3.6
3.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
71
737
0.95
0.11
3.7
3.5
ng/l
19.0
71.4
0.53
49
479
(4010399)
17
153
1.12
0.11
1.2
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
55
526
1.06
0.11
3.3
2.8
ng/l
1239.2
1072.7
0.13
46
428
(40760892) CBC W Ordered Manual Differential panel - Blood
40
421
0.94
0.10
4.5
4.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
35
370
0.94
0.09
3.4
2.0
mmol/l
2.5
2.4
2.25
30
319
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
5
46
1.09
0.09
3.0
3.0
ug/min
849.0
81.2
—
5
33
(3015736) pH of Urine
82
798
1.04
0.08
4.4
3.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
12
133
0.90
0.08
3.9
1.4
—
—
—
0
0
(4034850)
6
70
0.85
0.08
3.7
7.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
91
889
1.04
0.07
6.8
5.2
%
24.8
29.2
3.01
83
817
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
26
245
1.07
0.07
7.0
6.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
85
830
1.04
0.07
7.0
5.2
%
0.6
0.7
1.68
76
754
(46235355) HIV 1 and 2 tests - Meaningful Use set
27
285
0.94
0.07
1.6
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
8
90
0.88
0.07
1.0
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
39
405
0.96
0.06
1.2
1.3
u/ml
3.7
11.8
1.33
16
154
(3019069) Monocytes/100 leukocytes in Blood
89
873
1.03
0.05
6.8
5.3
%
8.3
8.0
0.48
80
807
(3041096) Erythrocytes [Presence] in Urine by Automated
55
565
0.97
0.05
4.7
3.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
51
524
0.97
0.05
4.8
4.1
estimate
0.0
0.0
0.00
17
181
(3037522) Nuclear Ab [Titer] in Serum
29
302
0.95
0.04
1.3
1.4
titre
400.0
600.0
—
8
85
(3009542) Hematocrit [Volume Fraction] of Blood
178
1792
0.97
0.03
20.3
12.8
%
37.9
39.5
1.27
117
1280
(3025941) Bacteria identified in Stool by Culture
13
122
1.07
0.02
1.1
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
129
1280
1.02
0.02
3.4
2.8
u/l
43.6
37.5
0.44
116
1187
(3011397) Hemoglobin [Presence] in Urine by Test strip
46
453
1.02
0.01
5.2
3.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
89
883
1.01
0.01
6.5
5.0
%
61.5
56.9
2.25
81
818
(3023520) Reticulocytes [#/volume] in Blood
14
134
1.05
0.00
2.4
3.0
e9/l
79.3
74.6
—
7
109
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
13
128
1.02
0.00
1.5
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
14
138
1.02
0.00
4.8
2.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
18
181
0.99
0.00
4.9
3.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
23
231
1.00
0.00
1.7
1.3
—
—
—
0
0
(3013512) EKG study
58
581
1.00
0.00
4.1
3.7
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
87
869
1.00
0.00
6.8
5.1
%
2.2
2.9
2.25
78
796
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
17
174
0.98
0.00
2.2
1.7
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
96
965
0.99
0.00
6.7
5.3
e9/l
0.2
0.2
0.73
81
843
(3028300) Cannabinoids [Presence] in Urine
5
56
0.89
0.00
1.2
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
7
72
0.97
0.00
1.9
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
56
0.89
0.00
1.2
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
56
0.89
0.00
1.2
1.3
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
7
0.00
0.00
0.0
1.7
—
216.1
—
0
7
(3032057) Clostridioides difficile [Presence] in Stool
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
56
0.89
0.00
1.2
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
53
0.94
0.00
1.2
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
77.6
—
0
5
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.5
—
8.8
—
0
6
(3043410) Blood group antigens tested for on Red Blood Cells
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
59
0.84
0.00
1.0
1.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
5
59
0.84
0.00
1.0
1.3
—
226.9
—
0
22
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
1.6
—
0
5
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
6
68
0.88
0.00
1.0
1.1
—
10.0
—
0
9
(3001186) Copper [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
16.7
—
0
6
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
5.6
—
26.0
—
0
5
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
99.2
—
0
5
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
454.2
—
0
5
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
184.0
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_OVARY_MUCINO_EXALLC – Mucinous and mucinous cystic tumor, excluding all cancers (controls excluding all cancers)
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).